Join Our Team

Career Opportunities

To be a part of our pioneering team of scientific investigators, please check our open positions. For consideration, please send your resume to us at careers@fatetherapeutics.com and reference the open position’s job code.

Open Positions

173DR, Scientist / Associate Scientist / Senior RA, Genome Biology

Job Code 173DR

Description

Fate Therapeutics is seeking a highly motivated and innovative research professional with expertise in human genome characterization studies by employing the latest genomics technologies (real-time quantitative PCR, Next Generation Sequencing (NGS), etc.). The successful candidate will be a key member of the Genomics team and support the development of genomic methods to fully characterize and understand Fate’s novel induced pluripotent stem cell (iPSC) – derived cellular therapy product candidates. The candidate is expected to have extensive experience in the latest molecular biology techniques including real-time PCR and NGS (DNA-seq, RNA-seq, ATAC-seq, Methyl-seq, Chip-seq, etc.). The candidate will be a key contributor within integrated and multidisciplinary teams solving complex problems while paving the way for precision development of the next generation cell-based immunotherapies in oncology and autoimmune diseases. This is a full-time position located at our corporate headquarters in San Diego.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 173DR.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

172PP, Scientist, Immunology

Job Code 172PP

Description

Fate’s Immune Regulatory Cell Therapy group is seeking a talented and highly motivated immunologist with expertise in myeloid cell immunology and autoimmunity to join a multidisciplinary team dedicated to the discovery of novel cellular therapeutics for the treatment of inflammatory and autoimmune disorders. The successful candidate will be responsible for identifying and implementing myeloid differentiation protocols from induced pluripotent stem cells (iPSC), the subsequent characterization of iPSC derived myeloid cells and their functional assessments in vitro and in murine models of immune disorders. In addition, the candidate will be involved in efforts to identify novel strategies to improve effector function and persistence of myeloid cell products through genetic engineering. The candidate must have in depth knowledge of myeloid cell immunology in addition to extensive experience with mammalian cell culture and animal immune disease modeling. The position will require individual, independent research as well as coordination with the reprogramming biology and engineering, immunology, in vivo biology and process development groups. This is a full-time position reporting to the Associate Director, Research and Development, and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 172PP.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

170SA, Senior Director, Quality

Job Code 170SA

Description

Fate Therapeutics is seeking an experienced Quality Assurance and Control professional to lead clinical stage development quality activities. In this key position, the individual will develop, implement, manage, audit, and maintain GxP (cGMP, GCP, and GLP) quality systems and will work across all disciplines (e.g., manufacturing, clinical development, research, and regulatory affairs) to ensure that Fate’s ongoing development program maintains regulatory compliance with local, state, federal, and international health authority requirements. Fate’s development programs involve novel cell therapies which present with unique product manufacturing, quality, and regulatory challenges. The ideal candidate should have experience in the area of cell therapy and/or biologics and knowledge of the pertinent regulations and how they apply to these fields. This is a full-time position reporting to the Chief Development Officer and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 170SA.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.

166JK, Director / Associate Director / Senior Manager, Data Management

Job Code 166JK

Description

Fate’s Biometrics team is currently seeking a skilled and motivated data management professional to contribute to and manage the database development and ongoing quality of the data for the Company’s clinical trials. This is a full-time position reporting to the Vice President, Biometrics and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 166JK.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Fate Therapeutics is headquartered in San Diego, CA.

159SW, Senior Director / Director, Corporate Communications & Investor Relations

Job Code 159SW

Description

Fate Therapeutics is seeking an experienced Corporate Communications & Investor Relations professional to proactively develop, implement and manage the Company’s communications and investor relations strategies and programs. Under the direction of the CEO, this position is expected to develop key communications strategies, mainly addressing the investor community, and shape cohesive external communications plans. He/she is required to be a strong writer and presenter, with the ability to understand and translate complicated science and concepts into easy to digest messages for broad audiences. This is a full-time position currently reporting to the CEO and is located at our corporate headquarters in San Diego, CA.

Download a PDF of the job description for more details:

View PDF

For consideration send cover letter and curriculum vitae to: careers@fatetherapeutics.com and reference job 159SW.

About Fate Therapeutics, Inc.

Fate Therapeutics is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapeutics for the treatment of cancer and immune disorders. The Company’s cell-based product pipeline is comprised of off-the-shelf immuno-oncology therapeutics, including NK- and T-cell-based candidates derived from induced pluripotent cells, and immuno-regulatory therapeutics, including hematopoietic cell-based candidates for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing auto-reactive T cells of patients with auto-immune disorders. Its adoptive cell therapy candidates are based on the Company’s novel ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells.